Global Ursodeoxycholic Acid Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated:
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Ursodeoxycholic Acid Market was valued at $750 mn. in 2025. During the forecast period 2025-2030, it is expected to grow at 10.5% CAGR, to an estimated market size of $1.2 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global Ursodeoxycholic Acid (UDCA) market comprises the production and distribution of a secondary bile acid used as a pharmaceutical therapy for hepatobiliary disorders. The scope includes its use as a first-line treatment for primary biliary cholangitis (PBC), the non-surgical dissolution of cholesterol gallstones, and management of liver complications in cystic fibrosis, while excluding alternative surgical interventions.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Ursodeoxycholic Acid Market in the period 2025-30:
- Rising global prevalence of chronic liver diseases and metabolic syndromes is driving the core demand for hepatoprotective therapies.
- Increasing off-label research into UDCA for treating non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is expanding the potential patient pool.
- The market is seeing a significant shift toward generic formulations as patent expirations lead to price erosion and increased accessibility in emerging economies.
- Innovation in drug delivery systems, such as modified-release capsules and liquid formats for pediatric use, is improving patient adherence and bioavailability.
- Advancements in diagnostic technologies are enabling earlier detection of rare autoimmune liver diseases, facilitating timely UDCA intervention.
- The aging global population is contributing to a higher incidence of gallstone-related disorders and chronic biliary conditions.
- Strategic industry consolidation through acquisitions is allowing major players to expand their manufacturing capacity and geographic reach.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Synthetic UDCA
- Extraction UDCA